Wayne Fenton: impact on food and drug administration.
Laughren
Thomas
T
thomas.laughren@fda.hhs.gov
D014150:Antipsychotic Agents / Q000627:therapeutic use; D003072:Cognition Disorders / Q000188:drug therapy; D015195:Drug Design; D049674:History, 21st Century; D006801:Humans; D008396:Maryland; D009315:National Institute of Mental Health (U.S.) / Q000266:history; D011570:Psychiatry / Q000266:history*; D012559:Schizophrenia / Q000188:drug therapy; D012565:Schizophrenic Psychology; D014481:United States; D014486:United States Food and Drug Administration / Q000266:history*
D014150:Antipsychotic Agents